l General Information |
Product Name | Amoxapine |
General description | Amoxapine is a tricyclic dibenzoxazepine (an N-aryl piperazine) which acts similarly to several other tricyclic antidepressants, amoxapine inhibits GLYT2a transport activity with IC50 of 92 μM. |
Synonym | CL 67772; 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine |
Purity | ≥98.0%(HPLC) | CAS Number | 14028-44-5 |
Formula | C17H16ClN3O | Molecular Weight | 313.785 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | Slightly soluble |
Water | Very slightly soluble |
l Biological Information |
Biochem/Physiol
Actions | Amoxapine is a tricyclic antidepressant of the dibenzoxazepine class. Amoxapine exerts its antidepressant effect by inhibiting the re-uptake of norepinephrine and, to a lesser degree, of serotonin, at adrenergic nerve endings and blocks the response of dopamine receptors to dopamine. This drug is used to treat symptoms of depression and may cause tardive dyskinesia. Amoxapine also binds to alpha-adrenergic, histaminergic, and cholinergic receptors which accounts for many of the side effects seen with this agent. |
Application | 1.Antidepressive Agents, Tricyclic 2.Dopamine Antagonists 3.Adrenergic Uptake Inhibitors 4.Neurotransmitter Uptake Inhibitors 5.Serotonin Uptake Inhibitors |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |